Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
NCT00116675
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
84
Enrollment
INDUSTRY
Sponsor class
Conditions
Warts
Interventions
DRUG:
Resiquimod
Sponsor
Graceway Pharmaceuticals, LLC